Reply to H.J.A. Adams et al and C. Kobe et al

Affiliations

¹ Sally F. Barrington, MBBS, MSc, Kings College London, London, United Kingdom; Elizabeth H. Phillips, MB and Nicholas Counsell, MSc, University College London, London, United Kingdom; and John Radford, MD, University of Manchester, Manchester, United Kingdom.

Comment

Sally F Barrington et al. J Clin Oncol. 2019.

. 2019 Dec 1;37(34):3325-3326.

doi: 10.1200/JCO.19.02056. Epub 2019 Sep 30.

¹ Sally F. Barrington, MBBS, MSc, Kings College London, London, United Kingdom; Elizabeth H. Phillips, MB and Nicholas Counsell, MSc, University College London, London, United Kingdom; and John Radford, MD, University of Manchester, Manchester, United Kingdom.

No abstract available

Comment on

Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study.
Barrington SF, Phillips EH, Counsell N, Hancock B, Pettengell R, Johnson P, Townsend W, Culligan D, Popova B, Clifton-Hadley L, McMillan A, Hoskin P, O'Doherty MJ, Illidge T, Radford J. Barrington SF, et al. J Clin Oncol. 2019 Jul 10;37(20):1732-1741. doi: 10.1200/JCO.18.01799. Epub 2019 May 21. J Clin Oncol. 2019. PMID: 31112475 Free PMC article. Clinical Trial.
Only a Small Proportion of Patients With Early-Stage Hodgkin Lymphoma May Potentially Benefit From Fluorodeoxyglucose-Positron Emission Tomography-Adapted Treatment Escalation.
Adams HJA, Kwee TC. Adams HJA, et al. J Clin Oncol. 2019 Dec 1;37(34):3323. doi: 10.1200/JCO.19.01491. Epub 2019 Sep 30. J Clin Oncol. 2019. PMID: 31566991 No abstract available.
Predictive Value of Positron Emission Tomography/Computed Tomography After ABVD-Based Chemotherapy in Early-Stage Hodgkin Lymphoma.
Kobe C, Goergen H, Fuchs M, Müller H, Baues C, Engert A, Dietlein M, von Tresckow B, Borchmann P. Kobe C, et al. J Clin Oncol. 2019 Dec 1;37(34):3324-3325. doi: 10.1200/JCO.19.01761. Epub 2019 Sep 30. J Clin Oncol. 2019. PMID: 31566995 No abstract available.